K Number
K063372
Date Cleared
2007-01-19

(72 days)

Product Code
Regulation Number
870.1330
Panel
CV
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Radifocus® Glidewire® Advantage is designed to direct a catheter to the desired anatomical location during diagnostic or interventional procedures.

Device Description

The Radifocus Glidewire Advantage consists of a Nickel Titanium alloy core wire. A polyurethane and hydrophilic coating is applied to the distal portion of the wire while a PTFE coating is applied to the proximal portion. The wire distal segment comes in many configurations such as straight, J shaped, and angled. The wire is package in a plastic holder contained within a pouch. A guide wire inserter is contained within the pouch to assist with the insertion of the wire into a needle or catheter.

AI/ML Overview

The provided text describes the 510(k) summary for the Radifocus® Glidewire® Advantage, a medical device. This document focuses on demonstrating substantial equivalence to a predicate device rather than presenting a study of the device's performance against specific acceptance criteria in a clinical setting.

Therefore, many of the requested details, such as the sample size for a test set, expert qualifications, adjudication methods, multi-reader multi-case studies, standalone performance, and details about training sets, are not applicable and not found within the provided text. This type of premarket notification relies on non-clinical performance testing and comparison to an already cleared device.

Here's a breakdown of the information that can be extracted from the provided text, along with explanations for the missing information:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not specify quantitative acceptance criteria in the typical sense (e.g., a specific percentage of success or a threshold for a metric). Instead, it states that the performance tests "demonstrate the substantial equivalence" and that "None of the data raises any new issues of safety and effectiveness."

Performance TestAcceptance Criteria (Implicit)Reported Device Performance Summary
Ease of removal from holderNo new issues of safety and effectiveness compared to predicatePerformance demonstrated substantial equivalence to the predicate device.
Torque controlNo new issues of safety and effectiveness compared to predicatePerformance demonstrated substantial equivalence to the predicate device.
Sliding frictionNo new issues of safety and effectiveness compared to predicatePerformance demonstrated substantial equivalence to the predicate device.
Tip impactNo new issues of safety and effectiveness compared to predicatePerformance demonstrated substantial equivalence to the predicate device.
Proximal shaft stiffnessNo new issues of safety and effectiveness compared to predicatePerformance demonstrated substantial equivalence to the predicate device.
Bend strengthNo new issues of safety and effectiveness compared to predicatePerformance demonstrated substantial equivalence to the predicate device.
BiocompatibilityCompliance with ISO-10993 (Part-1)Materials demonstrated biocompatibility as an "Externally Communicating Devices, Circulating Blood, Limited Contact (≤ 24 hrs)".
SterilizationCompliance with ANSI / AAMI / ISO 11135-1994, EN 550, SAL of 10-6Validated in accordance with standards to a SAL of 10-6.

2. Sample size used for the test set and the data provenance

  • Sample Size for Test Set: Not specified. The document refers to "verification tests" but does not give sample sizes for these tests.
  • Data Provenance: Not specified, but given the nature of the tests (mechanical and biocompatibility), it would be laboratory-based data, not human patient data.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

  • This information is not applicable to this type of submission. The performance tests are largely objective physical and chemical evaluations.

4. Adjudication method for the test set

  • This information is not applicable to this type of submission. The performance tests are objective evaluations against engineering specifications and biocompatibility standards.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, and the effect size of how much human readers improve with AI vs without AI assistance

  • This information is not applicable. This device is a guide wire, not an AI-powered diagnostic tool. No MRMC study was performed or mentioned.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

  • This information is not applicable. This device is a manual medical instrument, not an algorithm.

7. The type of ground truth used

  • For the mechanical performance tests (e.g., torque control, bend strength), the "ground truth" would be established engineering specifications or benchmarks derived from empirical data and comparison to the predicate device.
  • For biocompatibility, the "ground truth" is compliance with ISO-10993-1.
  • For sterilization, the "ground truth" is validation to established standards (ANSI / AAMI / ISO 11135-1994, EN 550) and achieving a Sterility Assurance Level (SAL) of 10-6.

8. The sample size for the training set

  • This information is not applicable. This is a physical medical device, not a machine learning algorithm.

9. How the ground truth for the training set was established

  • This information is not applicable. This is a physical medical device, not a machine learning algorithm.

§ 870.1330 Catheter guide wire.

(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.